Aquestive Therapeutics Inc (AQST)

Apr 26, 2025

The 14% return this week takes Aquestive Therapeutics' (NASDAQ:AQST) shareholders three-year gains to 105% - simplywall.st

Apr 26, 2025

Apr 26, 2025

Geode Capital Management LLC Trims Stock Position in Aquestive Therapeutics, Inc. (NASDAQ:AQST) - Defense World

Apr 26, 2025

Apr 25, 2025

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Apr 25, 2025

Apr 24, 2025

Russell Investments Group Ltd. Has $386,000 Holdings in Aquestive Therapeutics, Inc. (NASDAQ:AQST) - Defense World

Apr 24, 2025

Apr 23, 2025

Check out these key findings about Aquestive Therapeutics Inc (AQST) - Sete News

Apr 23, 2025

Apr 22, 2025

Is Aquestive Therapeutics Inc (AQST) worth investing in despite its overvalued state? - uspostnews.com

Apr 22, 2025

Apr 22, 2025

Recent Insider Activity Suggests Potential Gains for Aquestive Therapeutics Inc (AQST) - knoxdaily.com

Apr 22, 2025

Apr 22, 2025

Investor’s Delight: Aquestive Therapeutics Inc (AQST) Closes Strong at 2.58, Up 2.79 - DWinneX

Apr 22, 2025

Apr 21, 2025

Does Aquestive Therapeutics Inc (NASDAQ: AQST) Still Need To Convince Analysts? - Stocksregister

Apr 21, 2025

Apr 18, 2025

Vanguard Group Inc. Grows Stake in Aquestive Therapeutics, Inc. (NASDAQ:AQST) - Defense World

Apr 18, 2025

Apr 15, 2025

Wellington Management Group LLP Has $639,000 Stake in Aquestive Therapeutics, Inc. (NASDAQ:AQST) - Defense World

Apr 15, 2025

Apr 14, 2025

Strength Seen in Recursion Pharmaceuticals (RXRX): Can Its 27.7% Jump Turn into More Strength? - Yahoo Finance

Apr 14, 2025

Apr 11, 2025

Raymond James Financial Inc. Makes New Investment in Aquestive Therapeutics, Inc. (NASDAQ:AQST) - MarketBeat

Apr 11, 2025

Apr 09, 2025

Aquestive completes marketing application for Anaphylm in U.S. - MSN

Apr 09, 2025

Apr 09, 2025

Aquestive Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium - The Manila Times

Apr 09, 2025

Apr 09, 2025

Aquestive Therapeutics to Participate in Piper Sandler Spring Biopharma Symposium - GlobeNewswire Inc.

Apr 09, 2025

Apr 08, 2025

Raymond James Financial Inc. Invests $498,000 in Aquestive Therapeutics, Inc. (NASDAQ:AQST) - Defense World

Apr 08, 2025

Apr 07, 2025

What is HC Wainwright’s Estimate for AQST Q1 Earnings? - Defense World

Apr 07, 2025

Apr 04, 2025

HC Wainwright Reaffirms “Buy” Rating for Aquestive Therapeutics (NASDAQ:AQST) - Defense World

Apr 04, 2025

Apr 03, 2025

New Jersey Pharma Co. Shares Positive Pediatric Study - streetwisereports.com

Apr 03, 2025

Apr 03, 2025

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares Sold by HighTower Advisors LLC - Defense World

Apr 03, 2025

Apr 01, 2025

Aquestive’s Anaphylm shows promise in pediatric study By Investing.com - Investing.com South Africa

Apr 01, 2025

Apr 01, 2025

Aquestive’s Anaphylm shows promise in pediatric study - Investing.com India

Apr 01, 2025

Apr 01, 2025

Aquestive stock gains as Anaphylm NDA completes (AQST:NASDAQ) - Seeking Alpha

Apr 01, 2025

Apr 01, 2025

Aquestive Therapeutics Concludes FDA Application For Allergy Drug With Encouraging Pediatric Trial Data - Benzinga

Apr 01, 2025

Apr 01, 2025

Aquestive Therapeutics’ Anaphylm NDA Submission and Strong Clinical Profile Support Buy Rating - TipRanks

Apr 01, 2025

Apr 01, 2025

Aquestive Therapeutics Announces Positive Topline PK Results from its Pediatric Study and Completes the NDA Submission for Anaphylm™ (epinephrine) Sublingual Film - BioSpace

Apr 01, 2025

Apr 01, 2025

Aquestive Therapeutics Awaits FDA Decision on Anaphylm NDA - TipRanks

Apr 01, 2025

Apr 01, 2025

Aquestive Therapeutics Announces Positive Topline PK Results From Its Pediatric Study And Completes The NDA Submission For Anaphylm™ (Epinephrine) Sublingual Film - MENAFN.com

Apr 01, 2025

Apr 01, 2025

Charles Schwab Investment Management Inc. Grows Stock Holdings in Aquestive Therapeutics, Inc. (NASDAQ:AQST) - Defense World

Apr 01, 2025

Mar 31, 2025

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives Average Rating of “Buy” from Analysts - Defense World

Mar 31, 2025

Mar 30, 2025

Aquestive stock falls amid Libervant approval, Anaphylm update - MSN

Mar 30, 2025

Mar 27, 2025

Bank of New York Mellon Corp Reduces Stock Position in Aquestive Therapeutics, Inc. (NASDAQ:AQST) - Defense World

Mar 27, 2025

Mar 25, 2025

Aquestive Therapeutics: Oral Anaphylaxis NDA Opportunity Spells Buy - Seeking Alpha

Mar 25, 2025

Mar 24, 2025

Aquestive Therapeutics: Not For Me, But Attractive (NASDAQ:AQST) - Seeking Alpha

Mar 24, 2025

Mar 21, 2025

Aquestive Therapeutics, Inc.'s (NASDAQ:AQST) P/S Is On The Mark - simplywall.st

Mar 21, 2025

Mar 12, 2025

What is HC Wainwright’s Forecast for AQST FY2026 Earnings? - Defense World

Mar 12, 2025

Mar 11, 2025

Aquestive Therapeutics (NASDAQ:AQST) Given Buy Rating at HC Wainwright - Defense World

Mar 11, 2025

Mar 10, 2025

Aquestive Therapeutics’ Earnings Call: Progress Amid Challenges - TipRanks

Mar 10, 2025

Mar 10, 2025

Aquestive Therapeutics Advances Product Pipeline and Market Access - TipRanks

Mar 10, 2025

Mar 10, 2025

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 10, 2025

Mar 10, 2025

Buy Rating on Aquestive Therapeutics Driven by Anaphylm’s Regulatory Progress and Strategic Launch Preparations - TipRanks

Mar 10, 2025